DE1138509B - Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen - Google Patents
Verfahren zur Herstellung von Maul- und Klauenseuche-KonzentratvaccinenInfo
- Publication number
- DE1138509B DE1138509B DEB55507A DEB0055507A DE1138509B DE 1138509 B DE1138509 B DE 1138509B DE B55507 A DEB55507 A DE B55507A DE B0055507 A DEB0055507 A DE B0055507A DE 1138509 B DE1138509 B DE 1138509B
- Authority
- DE
- Germany
- Prior art keywords
- concentrate
- foot
- mouth disease
- virus
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960005486 vaccine Drugs 0.000 title claims description 18
- 239000012141 concentrate Substances 0.000 title claims description 11
- 238000000034 method Methods 0.000 title claims description 10
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 241000710198 Foot-and-mouth disease virus Species 0.000 title claims description 6
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 title claims description 3
- 241000700605 Viruses Species 0.000 claims description 16
- 239000000725 suspension Substances 0.000 claims description 11
- -1 Fatty alcohol sulfate Chemical class 0.000 claims description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 7
- 239000008098 formaldehyde solution Substances 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000002779 inactivation Effects 0.000 claims description 3
- 238000005199 ultracentrifugation Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 239000006228 supernatant Substances 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000002255 vaccination Methods 0.000 description 3
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 241000700198 Cavia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB55507A DE1138509B (de) | 1959-11-12 | 1959-11-12 | Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen |
| LU39322D LU39322A1 (enrdf_load_stackoverflow) | 1959-11-12 | 1960-10-22 | |
| BE597049A BE597049A (fr) | 1959-11-12 | 1960-11-14 | Procédé de préparation de vaccins antiaphteux concentrés |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB55507A DE1138509B (de) | 1959-11-12 | 1959-11-12 | Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1138509B true DE1138509B (de) | 1962-10-25 |
Family
ID=6971014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEB55507A Pending DE1138509B (de) | 1959-11-12 | 1959-11-12 | Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE597049A (enrdf_load_stackoverflow) |
| DE (1) | DE1138509B (enrdf_load_stackoverflow) |
| LU (1) | LU39322A1 (enrdf_load_stackoverflow) |
-
1959
- 1959-11-12 DE DEB55507A patent/DE1138509B/de active Pending
-
1960
- 1960-10-22 LU LU39322D patent/LU39322A1/xx unknown
- 1960-11-14 BE BE597049A patent/BE597049A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE597049A (fr) | 1961-05-15 |
| LU39322A1 (enrdf_load_stackoverflow) | 1960-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0011243B1 (de) | Verfahren zur Herstellung von Membranproteinen aus Neisseria meningitidis und diese enthaltende Vaccine | |
| DE2355094A1 (de) | Tetanus-vaccine und verfahren zu deren herstellung | |
| DE2803240B2 (de) | Tollwutvirus, Verfahren zur Herstellung eines ToUwut-Lebendimpfstoffs oder inaktivierten Impfstoffs und seine Verwendung bei der Bekämpfung von Tollwut | |
| DE2816942C2 (de) | Impfstoff gegen Rhinitis atrophicans beim Schwein | |
| DE1198489B (de) | Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie | |
| DE1017744B (de) | Verfahren zur Gewinnung von wachstumsfoerdernden Stoffen fuer therapeutische Zwecke | |
| DE1138509B (de) | Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen | |
| DE2328579A1 (de) | Varicella-vaccine | |
| DE664023C (de) | Verfahren zur Darstellung von Milz- und Leberextrakten | |
| DE3019554C2 (enrdf_load_stackoverflow) | ||
| DE959048C (de) | Verfahren zur Herstellung eines Impfstoffes zur aktiven Schutzimpfung gegen spinale Kinderlaehmung | |
| DE2225548A1 (de) | Intravenoes vertraegliche staupe- und hepatitisvaccine | |
| DE539018C (de) | Verfahren zur Herstellung lokal immunisierend wirkender Stoffe aus Bakterien (Staphylokokken, Streptokokken, Bacterium coli) | |
| DE212709C (enrdf_load_stackoverflow) | ||
| DE908909C (de) | Verfahren zur Herstellung und Verarbeitung pathogener Viren und der sie begleitenden Stoffe | |
| DE2033946C2 (de) | Lebendimpfstoff gegen infektiöse pustulöse Vulvovaginitis [IPV] und infektiöse bovine Rhinotracheitis [IBR] | |
| DE1057733B (de) | Herstellung einer konzentrierten Vakzine gegen Maul- und Klauenseuche | |
| DE1617548C3 (de) | Verfahren zur Herstellung eines Impfstoffs gegen die Maul- und Klauenseuche | |
| AT36199B (de) | Verfahren zur Herstellung von Immunisierungs- und Heilmitteln gegen Infektionskrankheiten. | |
| DE338166C (de) | Verfahren zur Herstellung unschaedlicher Impfstoffe aus gifthaltigen pathogenen Mikroorganismen | |
| AT200257B (enrdf_load_stackoverflow) | ||
| DE739594C (de) | Verfahren zur Herstellung eines Heil- und Schutzserums gegen Staupe | |
| AT226365B (de) | Verfahren zur Herstellung von Impfstoffen aus Gewebekulturen gegen ansteckende Schweinelähmung | |
| DE3150935A1 (de) | Verfahren zur herstellung eines hepatitis-b impfstoffes | |
| DE1138888B (de) | Verfahren zur Herstellung einer Vaccine gegen Staupe |